JP2025063147A5 - - Google Patents

Info

Publication number
JP2025063147A5
JP2025063147A5 JP2025003824A JP2025003824A JP2025063147A5 JP 2025063147 A5 JP2025063147 A5 JP 2025063147A5 JP 2025003824 A JP2025003824 A JP 2025003824A JP 2025003824 A JP2025003824 A JP 2025003824A JP 2025063147 A5 JP2025063147 A5 JP 2025063147A5
Authority
JP
Japan
Prior art keywords
cancer
seq
probe
pancreatic
formulated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025003824A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025063147A (ja
Filing date
Publication date
Priority claimed from PCT/US2020/014110 external-priority patent/WO2020150617A2/en
Application filed filed Critical
Publication of JP2025063147A publication Critical patent/JP2025063147A/ja
Publication of JP2025063147A5 publication Critical patent/JP2025063147A5/ja
Pending legal-status Critical Current

Links

JP2025003824A 2019-01-17 2025-01-10 腫瘍細胞外マトリックスにおける腫瘍性タンパク質に特異的なペプチドpet/spectプローブ Pending JP2025063147A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962793789P 2019-01-17 2019-01-17
US62/793,789 2019-01-17
PCT/US2020/014110 WO2020150617A2 (en) 2019-01-17 2020-01-17 Peptide pet/spect probes specific to oncoproteins in tumor extracellula matrix
JP2021541620A JP7702871B2 (ja) 2019-01-17 2020-01-17 腫瘍細胞外マトリックスにおける腫瘍性タンパク質に特異的なペプチドpet/spectプローブ

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021541620A Division JP7702871B2 (ja) 2019-01-17 2020-01-17 腫瘍細胞外マトリックスにおける腫瘍性タンパク質に特異的なペプチドpet/spectプローブ

Publications (2)

Publication Number Publication Date
JP2025063147A JP2025063147A (ja) 2025-04-15
JP2025063147A5 true JP2025063147A5 (https=) 2025-10-07

Family

ID=71614081

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021541620A Active JP7702871B2 (ja) 2019-01-17 2020-01-17 腫瘍細胞外マトリックスにおける腫瘍性タンパク質に特異的なペプチドpet/spectプローブ
JP2025003824A Pending JP2025063147A (ja) 2019-01-17 2025-01-10 腫瘍細胞外マトリックスにおける腫瘍性タンパク質に特異的なペプチドpet/spectプローブ

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021541620A Active JP7702871B2 (ja) 2019-01-17 2020-01-17 腫瘍細胞外マトリックスにおける腫瘍性タンパク質に特異的なペプチドpet/spectプローブ

Country Status (8)

Country Link
US (1) US12576168B2 (https=)
EP (1) EP3911373A4 (https=)
JP (2) JP7702871B2 (https=)
KR (1) KR20210115003A (https=)
CN (1) CN113727737A (https=)
AU (1) AU2020208492B2 (https=)
CA (1) CA3127188A1 (https=)
WO (1) WO2020150617A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112574280B (zh) * 2020-12-21 2022-05-17 北京大学第一医院 一种双酶体系探针及其应用
US20240252662A1 (en) * 2021-05-20 2024-08-01 Case Western Reserve University Peptide drug conjugates specific to fibronectin isotypes for cancer therapy
CN116370658B (zh) * 2023-03-08 2025-04-18 中国科学院深圳先进技术研究院 一种靶向肿瘤的超声造影剂及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9011816B2 (en) * 2011-03-25 2015-04-21 Case Western Reserve University Fibronectin targeting contrast agent
WO2013106824A1 (en) * 2012-01-13 2013-07-18 Board Of Regents, The University Of Texas System Epherin receptor targeting agents
WO2016022597A1 (en) * 2014-08-04 2016-02-11 Case Western Reserve University Targeting peptides and methods of use
US10925980B2 (en) * 2014-08-04 2021-02-23 Case Western Reserve University Molecular probes and methods of use
CA3060143A1 (en) 2017-05-24 2018-11-29 Itm Isotopen Technologien Munchen Ag Novel psma-binding agents and uses thereof

Similar Documents

Publication Publication Date Title
JP2025063147A5 (https=)
Rohren et al. Clinical applications of PET in oncology
ES2729555T3 (es) Inhibidores homomultivalentes y heteromultivalentes de antígeno de membrana específico de próstata (PMSA) y usos de los mismos
ES2700234T3 (es) Inhibidores marcados del antígeno de membrana específico de la próstata (PSMA), evaluación biológica y uso como agentes para la obtención de imágenes
CN115304582B (zh) FAP-α特异性肿瘤诊断显像剂
EP3978033A1 (en) Rk polypeptide radiopharmaceutical targeting her2, and preparation method therefor
CN119638678B (zh) 一种靶向Her2核素探针及其制备方法和应用
CN118955478B (zh) 谷氨酸尿素类化合物及其制备方法和应用、核素靶向探针及其制备方法和应用、药物组合物
CN119330937B (zh) 一种靶向cxcr4受体的探针前体、探针及其制备方法与应用
CN115745903B (zh) 一种肽脲素衍生物、含其的药物组合物及其应用
CN119331049A (zh) 靶向cxcr4受体的二聚体标记前体及由其衍生的放射性示踪剂
CN119930631B (zh) 一种靶向ddr1受体的化合物及其衍生的放射性示踪剂
CN103435684B (zh) 18f-氟标记五肽配合物及合成方法
Krabbe et al. Detection of cervical metastases with 11C‐tyrosine pet in patients with squamous cell carcinoma of the oral cavity or oropharynx: A comparison with 18F‐FDG PET
Treglia et al. The role of nuclear medicine in the management of thymomas
TWI633099B (zh) 造影劑前驅物及其製備方法
Liu et al. Multimodality imaging and preclinical evaluation of 177Lu-AMBA for human prostate tumours in a murine model
US9981953B1 (en) Contrast agent precursor and method for preparing the same
Colmenter et al. Value of the 18F-FDG-PET/CT in the initial staging of patients with high-risk thyroid cancer with aggressive histological subtypes.
Świętowicz et al. The role of radioisotope imaging techniques in the breast cancer diagnosis
CN118955383A (zh) 新型靶向前列腺特异性膜抗原的肿瘤诊疗一体化试剂
TW201914617A (zh) 多鏈醣複合物、放射性多鏈醣造影劑及其用途
JP2012042215A (ja) 早期膵がんの検出方法
US20190071429A1 (en) Multiple-functional probe and uses thereof
Shan 99mTc-2-[Bis-(2-mercaptoethyl)] aminoethanethiol-4-isocyano-N-[2-(2-methyl-5-nitro-1H-imidazol-1-yl) ethyl] butanamide